Biomea Fusion, Inc. (BMEA)

1.325 -0.16 (-11.07%) USD  |  NASDAQ  |  Sep 25, 16:00
1.325 0.00 (0.00%) After-Hours: 19:59
More

Biomea Fusion Research and Development Expense (Annual) : 61.98M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for BMEA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 61.98M
December 31, 2024 118.08M
December 31, 2023 102.55M
December 31, 2022 62.71M
Date Value
December 31, 2021 28.00M
December 31, 2020 3.671M
December 31, 2019 1.092M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
REGENXBIO, Inc. 212.68M
ACADIA Pharmaceuticals, Inc. 328.80M
Alnylam Pharmaceuticals, Inc. 1.320B
Anika Therapeutics, Inc. 25.77M
Savara, Inc. 81.40M